AR and breast carcinoma: Other studies too have found that breast cancers with discordant ER/AR expressions (ER+/AR- or ER−/AR+) demonstrated a worse prognosis in comparison to breast cancers with concordant expression (ER + AR+ or ER−/AR -) in multivariable models [33].